United States · Platforms & data · MarketBeat

HLS Therapeutics Targets 2027 Growth With Cardiovascular Expansion and New Deals

Published by MarketBeat · United States 1 h ago

HLS Therapeutics (TSE:HLS) outlined plans to build on its cardiovascular portfolio and pursue additional business-development opportunities as the specialty pharmaceutical company…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Australia's Q3 PPI rises 1.1% Q/Q; annual producer inflation holds steady at 3.6%

The Motley Fool

These 2 Nearly 100% Historically Accurate Market Signals Are Conflicting. Here's What Investors Should Do.

Investing.com

BYD shares dip as Q3 earnings disappoint

MarketWatch

What gave this city its ‘best place to retire’ crown? You can actually afford to live there.

Yahoo Finance

Sify (SIFY) Q2 2027 Earnings Call Transcript

TipRanks